ITRM930409A0 - Metodologia per la selezione di superagonisti, antagonisti e super antagonisti di ormoni del cui complesso recettoriale fa parte gp 130. - Google Patents

Metodologia per la selezione di superagonisti, antagonisti e super antagonisti di ormoni del cui complesso recettoriale fa parte gp 130.

Info

Publication number
ITRM930409A0
ITRM930409A0 IT93RM409A ITRM930409A ITRM930409A0 IT RM930409 A0 ITRM930409 A0 IT RM930409A0 IT 93RM409 A IT93RM409 A IT 93RM409A IT RM930409 A ITRM930409 A IT RM930409A IT RM930409 A0 ITRM930409 A0 IT RM930409A0
Authority
IT
Italy
Prior art keywords
antagonists
superagonists
hormones
methodology
super
Prior art date
Application number
IT93RM409A
Other languages
English (en)
Inventor
Rocco Savino
Gennaro Ciliberto
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Publication of ITRM930409A0 publication Critical patent/ITRM930409A0/it
Priority to ITRM930409A priority Critical patent/IT1261787B/it
Priority to CN94190533.0A priority patent/CN1101937C/zh
Priority to AU71324/94A priority patent/AU687416B2/en
Priority to PT94920582T priority patent/PT656117E/pt
Priority to CN02107480.1A priority patent/CN1249439C/zh
Priority to JP7502633A priority patent/JP2643604B2/ja
Priority to PCT/IT1994/000095 priority patent/WO1995000852A2/en
Priority to AT94920582T priority patent/ATE189528T1/de
Priority to DE69422893T priority patent/DE69422893T2/de
Priority to EP94920582A priority patent/EP0656117B1/en
Priority to CA002142973A priority patent/CA2142973C/en
Priority to DK94920582T priority patent/DK0656117T3/da
Priority to HK98111980.2A priority patent/HK1011081B/en
Priority to ES94920582T priority patent/ES2144524T3/es
Publication of ITRM930409A1 publication Critical patent/ITRM930409A1/it
Priority to US08/567,048 priority patent/US5891998A/en
Priority to US08/567,047 priority patent/US5789552A/en
Application granted granted Critical
Publication of IT1261787B publication Critical patent/IT1261787B/it
Priority to GR20000400800T priority patent/GR3033111T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ITRM930409A 1993-06-23 1993-06-23 Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130. IT1261787B (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
ITRM930409A IT1261787B (it) 1993-06-23 1993-06-23 Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130.
DE69422893T DE69422893T2 (de) 1993-06-23 1994-06-23 Methode zur auswahl von superagonisten, antagonisten und superantagonisten von interleukin 6
CA002142973A CA2142973C (en) 1993-06-23 1994-06-23 A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130
PT94920582T PT656117E (pt) 1993-06-23 1994-06-23 Metodo de seleccao de superagonistas de antagonistas e de superantagonistas da interleucina 6
CN02107480.1A CN1249439C (zh) 1993-06-23 1994-06-23 一种白细胞介素6受体拮抗剂
JP7502633A JP2643604B2 (ja) 1993-06-23 1994-06-23 受容体複合体がｇｐ１３０を含むホルモンのスーパーアゴニスト，アンタゴニスト，及びスーパーアンタゴニストを選択するための方法
PCT/IT1994/000095 WO1995000852A2 (en) 1993-06-23 1994-06-23 A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130
AT94920582T ATE189528T1 (de) 1993-06-23 1994-06-23 Methode zur auswahl von superagonisten, antagonisten und superantagonisten von interleukin 6
CN94190533.0A CN1101937C (zh) 1993-06-23 1994-06-23 一种筛选利用膜分子gp130激活细胞生理调节机制的激素的拮抗剂和超拮抗剂的方法
EP94920582A EP0656117B1 (en) 1993-06-23 1994-06-23 A methodology for selecting superagonists, antagonists and superantagonists of interleukin 6
AU71324/94A AU687416B2 (en) 1993-06-23 1994-06-23 A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes GP 130
DK94920582T DK0656117T3 (da) 1993-06-23 1994-06-23 Fremgangsmåde til udvælgelse af superagonister, antagonister og superantagonister for interleukin 6
HK98111980.2A HK1011081B (en) 1993-06-23 1994-06-23 A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130
ES94920582T ES2144524T3 (es) 1993-06-23 1994-06-23 Metodologia para seleccionar superagonistas, antagonistas y superantagonistas de la interleuquina 6.
US08/567,048 US5891998A (en) 1993-06-23 1995-12-04 Interleukin-6 receptor agonists
US08/567,047 US5789552A (en) 1993-06-23 1995-12-04 Interleukin-6 receptor antagonists
GR20000400800T GR3033111T3 (en) 1993-06-23 2000-03-29 A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930409A IT1261787B (it) 1993-06-23 1993-06-23 Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130.

Publications (3)

Publication Number Publication Date
ITRM930409A0 true ITRM930409A0 (it) 1993-06-23
ITRM930409A1 ITRM930409A1 (it) 1994-12-23
IT1261787B IT1261787B (it) 1996-06-03

Family

ID=11401818

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM930409A IT1261787B (it) 1993-06-23 1993-06-23 Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130.

Country Status (13)

Country Link
EP (1) EP0656117B1 (it)
JP (1) JP2643604B2 (it)
CN (2) CN1249439C (it)
AT (1) ATE189528T1 (it)
AU (1) AU687416B2 (it)
CA (1) CA2142973C (it)
DE (1) DE69422893T2 (it)
DK (1) DK0656117T3 (it)
ES (1) ES2144524T3 (it)
GR (1) GR3033111T3 (it)
IT (1) IT1261787B (it)
PT (1) PT656117E (it)
WO (1) WO1995000852A2 (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276555B1 (it) * 1995-04-28 1997-11-03 Angeletti P Ist Richerche Bio Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
IT1277926B1 (it) * 1995-09-01 1997-11-12 Angeletti P Ist Richerche Bio Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire
US5849293A (en) * 1996-01-11 1998-12-15 Cornell Research Foundation, Inc. Use of human transferrin in controlling insulin levels
IT1285790B1 (it) * 1996-09-24 1998-06-24 Angeletti P Ist Richerche Bio Adenovirus difettivi ricombinanti che codificano per mutanti di interleuchina 6 umana (hil-6) con attivita' antagonista o
EP2011514B1 (en) 1997-03-21 2012-02-29 Chugai Seiyaku Kabushiki Kaisha A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient
GB9806530D0 (en) 1998-03-26 1998-05-27 Glaxo Group Ltd Inflammatory mediator
WO2003033015A1 (en) 2001-10-11 2003-04-24 Applied Research Systems Ars Holding N.V. USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY
FR2833011B1 (fr) * 2001-12-04 2004-10-29 Univ Claude Bernard Lyon Nouvelle proteine a activite inhibitrice de l'il-6
IL161673A0 (en) 2004-04-29 2004-09-27 Applied Research Systems Compositions and methods for therapy of chemotherapy-induced neuropathy
CN101246160B (zh) * 2007-09-06 2012-11-21 三峡大学 在体外用ELISA方法建立的IL-6/sIL-6R结合的分子模型
DE102011104822A1 (de) 2011-06-18 2012-12-20 Christian-Albrechts-Universität Zu Kiel Ciliary-Neutrophic-Factor-Varianten
WO2013147153A1 (ja) 2012-03-29 2013-10-03 株式会社未来創薬研究所 抗ｌａｍｐ５抗体およびその利用
WO2018104564A2 (en) * 2017-08-11 2018-06-14 Solvay Specialty Polymers Italy S.P.A. Method for stabilizing aqueous dispersions of fluorinated polymers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990004788A1 (en) * 1988-10-28 1990-05-03 Genentech, Inc. Method for identifying active domains and amino acid residues in polypeptides and hormone variants
JP2898064B2 (ja) * 1989-08-03 1999-05-31 忠三 岸本 ヒトｇｐ１３０蛋白質
JP2898040B2 (ja) * 1990-01-26 1999-05-31 忠三 岸本 ｇｐ１３０蛋白質に対する抗体
US5210075A (en) * 1990-02-16 1993-05-11 Tanabe Seiyaku Co., Ltd. Interleukin 6 antagonist peptides
ATE196548T1 (de) * 1991-05-10 2000-10-15 Genentech Inc Auswählen von agonisten und antagonisten von liganden
AU687763B2 (en) * 1992-10-20 1998-03-05 Central Laboratory Of The Netherlands Red Cross Blood Transfusion Service Interleukin-6 receptor antagonists
US5470952A (en) * 1993-10-20 1995-11-28 Regeneron Pharmaceuticals, Inc. CNTF and IL-6 antagonists
US5939534A (en) * 1993-12-29 1999-08-17 Sumitomo Pharmaceuticals Company, Limited Factors mutated in the D1 cap region

Also Published As

Publication number Publication date
WO1995000852A3 (en) 1995-03-30
DE69422893D1 (de) 2000-03-09
DE69422893T2 (de) 2000-08-17
ES2144524T3 (es) 2000-06-16
ITRM930409A1 (it) 1994-12-23
IT1261787B (it) 1996-06-03
EP0656117B1 (en) 2000-02-02
JPH07509571A (ja) 1995-10-19
HK1011081A1 (en) 1999-07-02
CN1538176A (zh) 2004-10-20
AU687416B2 (en) 1998-02-26
CA2142973A1 (en) 1995-01-05
DK0656117T3 (da) 2000-07-24
GR3033111T3 (en) 2000-08-31
CN1101937C (zh) 2003-02-19
PT656117E (pt) 2000-07-31
CN1249439C (zh) 2006-04-05
CA2142973C (en) 2004-10-26
AU7132494A (en) 1995-01-17
ATE189528T1 (de) 2000-02-15
EP0656117A1 (en) 1995-06-07
JP2643604B2 (ja) 1997-08-20
CN1112795A (zh) 1995-11-29
WO1995000852A2 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
ITRM940805A0 (it) Metodo per selezionare superagonisti, antagonisti e superantagonisti di ormoni del cui complesso recettoriale fa parte gp 130
ITRM930409A0 (it) Metodologia per la selezione di superagonisti, antagonisti e super antagonisti di ormoni del cui complesso recettoriale fa parte gp 130.
EE03241B1 (et) Androstenooni derivaat 17ß-N-(2,5-bis(trifluorometüül))fenüülkarbamoüül-4-asa-5a-androst-1-een-3-oon ja selle farmatseutiliselt vastuvõetavad solvaadid
FR2712466B1 (fr) Lacet de chaussure résistant au glissement, et son procédé de fabrication.
DE69005388D1 (de) Rückenspritze.
TR199600028A2 (tr) 2,9-disübstitüe edilmis purin-6-onlar.
ITMI911672A1 (it) Procedimento per l'impiego di un robot e dispositivo relativo.
NO993647D0 (no) Endotelinantagonist
FR2714272B3 (fr) Porte-monnaie annulaire.
DE50201499D1 (de) Spreizdübel
NO890229D0 (no) Metallekstraksjonsprosess.
NO904449D0 (no) Aramidfiber, fremgangsmaate for fremstilling av denne og anvendelse av denne.
ITMI911604A1 (it) Procedimento per la preparazione della n- (2, 6-diclorofenil) -n-fenil-n-(cloroacetil)-ammina.
ZA929761B (en) Enhancing the bioavailability of proteolytically labile therapeutic agents.
DE59002436D1 (de) Nagelschlagbacken.
ITMI911767A1 (it) ANTICORPI POLICLONALI ANTI-IRUDINA E LORO UTILIZZO PER LA IDENTIFICAZIONE, LyIMMUNOPURIFICAZIONE E LA DETERMINAZIONE QUANTITATIVA DELLyURIDINA.
DE69434974D1 (de) alpha-2,8 SIALYLTRANSFERASE
IT1292459B1 (it) Convogliatore per macchine cucitrici per la chiusura della punta di calze o simili,ad elevata versatilita' di impiego
TR199600579A2 (tr) N-N-Dietil-8,8-Dipropil-2-Azaspiro (4.5) Dekan-2-propanamid dimaleat.
NO913334D0 (no) Gemfibrozil-holdig preparat, samt fremgangsmaate for fremstilling av et slikt.
IT232827Y1 (it) Finitura per borse,valige e simili.
FI906269A0 (fi) 2,19-metylenoxi- och 2,19-metylentio -tvaerbundna steroider som aromatas- och 19-hydroxylasinhibitorer.
IT9048169A0 (it) Dispositivo per salpare l'ancora applicabile ai tubolari pneumatici di gommoni, canotti e simili.
KR950016245U (ko) 농업용 상, 하 작동식 분무장치
IT218251Z2 (it) Monile applicabile preferibilmente sulla parte annodata di cravatta o similari.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970328